€ 1.02
Key Takeaways
Risk factor
Very poor trading liquidity
Profitability factor
Excellent dividends
About
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally. The company offers over the counter (OTC) pharmaceutical and traded goods, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care products. It also provides logistics, advisory, sales and marketing, and expert services for pharmaceutical companies, pharmacies, hospital pharmacies, veterinaries, as well...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, undervalued on EV/EBIT
Target Price
The average target price of OKDBV.HE is 1.1 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati
